R. Schuligoi et al., RELEASE OF CALCITONIN-GENE-RELATED PEPTIDE IN CARDIAC ANAPHYLAXIS, Naunyn-Schmiedeberg's archives of pharmacology, 355(2), 1997, pp. 224-229
We have investigated the antigen-stimulated release of calcitonin gene
-related peptide (CGRP) from ovalbumin-sensitized guinea-pig isolated
hearts and the interaction with other mediators of anaphylaxis release
d concomitantly. It was found that antigen challenge caused a signific
ant increase of CGRP release (from basal 31.2 +/- 2.9 to 51.6 +/- 4.9
fmol/5 min). Anaphylactic CGRP release was significantly attenuated in
the presence of the cyclooxygenase inhibitor indomethacin while the 5
-lipoxygenase inhibitor Bay-X1005 )-2-[4-quinolin-2-yl-methoxy)phenyl]
-2-cyclopentyl acetic acid) had no significant effect. Combined treatm
ent with the histamine receptor (H-1, H-2) antagonists mepyramine and
cimetidine also significantly attenuated anaphylactic release of CGRP
Under control conditions antigen injection increased release of cystei
nyl-leukotrienes (LT), thromboxane (TXB(2)) and 6-keto-prostaglandin (
PG)F-1 alpha from basal values of 0.96 +/- 0.09, 2.7 +/- 0.7 and 3.4 /- 0.28 ng/5 min respectively, to 5.9 +/- 0.9, 48.4 +/- 3.4 and 6.9 +/
- 1.4 ng/5 min. Indomethacin abolished the release of cyclooxygenase p
roducts of arachidonate metabolism and simultaneously increased cystei
nyl-LT release significantly (8.8 +/- 1.4 ng/5 min). Conversely Bay-X1
005 completely abolished cysteinyl-LT release and had no significant e
ffect on anaphylactic release of TXB(2) and 6-keto-PGF(1 alpha). Simul
taneous blockade of H-1 and H-2 receptors abolished release of 6-keto-
PGF(1 alpha), while release of TXB(2) and cysteinyl-LT was not signifi
cantly affected. The results indicate that CGRP is not a primary media
tor of the immediate hypersensitivity reaction of the heart, but is in
turn released by arachidonic acid metabolites of the cyclooxygenase p
athway and histamine. In contrast, LT obviously do not contribute to a
naphylactic CGRP release. CGRP is a potent coronary vasodilator and co
uld act as endogenous functional antagonist of vasoconstrictor mediato
rs also released during cardiac anaphylaxis such as cysteinyl-LT, plat
elet activating factor and TXA(2).